RxSight, Inc.
RXST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17 | $10 | $12 | $24 |
| Short-Term Investments | $221 | $117 | $94 | $135 |
| Receivables | $30 | $20 | $11 | $5 |
| Inventory | $22 | $17 | $15 | $8 |
| Other Curr. Assets | $5 | $4 | $3 | $4 |
| Total Curr. Assets | $294 | $168 | $135 | $176 |
| Property Plant & Equip (Net) | $24 | $13 | $14 | $16 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $2 | $1 |
| Total NC Assets | $25 | $14 | $16 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $319 | $183 | $150 | $193 |
| Liabilities | – | – | – | – |
| Payables | $5 | $4 | $3 | $2 |
| Short-Term Debt | $1 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $3 | $2 | $1 | $1 |
| Other Curr. Liab. | $17 | $13 | $11 | $7 |
| Total Curr. Liab. | $26 | $21 | $17 | $11 |
| LT Debt | $11 | $1 | $43 | $43 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $11 | $1 | $43 | $43 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $12 | $3 | $5 | $5 |
| Total Liabilities | $37 | $22 | $60 | $54 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$622 | -$595 | -$546 | -$479 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $903 | $755 | $636 | $618 |
| Total Equity | $281 | $160 | $90 | $138 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $319 | $183 | $150 | $193 |
| Net Debt | -$4 | -$7 | $33 | $21 |